1. |
YANG Huan,TRACEY K J.Targeting HMGB1 in inflammation[J].Biochim Biophys Acta,2010,1799(1-2):149-156.
|
2. |
IBRAHIM Z A,ARMOUR C L,PHIPPS S,et al.RAGE and TLRs:Relatives,friends or neighbours?[J].Mol Immunol,2013,56(4):739-744.
|
3. |
TANG Daolin,LOTZE M T.Tumor immunity times out:TIM-3 and HMGB1[J].Nat Immunol,2012,13(9):808-810.
|
4. |
YANAI H,BAN T,TANIGUCHI T.High-mobility group box family of proteins:ligand and sensor for innate immunity[J].Trends Immunol,2012,33(12):633-640.
|
5. |
LI Guanqiao,LIANG Xiaoyan,LOTZE M T.HMGB1:the central cytokine for all lymphoid cells[J].Front Immunol,2013,4:68.
|
6. |
CULLY M.Connective tissue diseases:HMGB1 helps elicit anti-dsDNA antibody production in SLE[J].Nat Rev Rheumatol,2013,9(6):321.
|
7. |
GNANASEKAR M,KALYANASUNDARAM R,ZHENG Guoxing,et al.HMGB1:A promising therapeutic target for prostate cancer[J].Prostate Cancer,2013,2013:157103.
|
8. |
NOGUEIRA-MACHADO J A,DE OLIVEIRA VOLPE C M.HMGB-1 as a target for inflammation controlling[J].Recent Pat Endocr Metab Immune Drug Discov,2012,6(3):201-209.
|
9. |
RADIN J N,GONZÁLEZ-RIVERA C,IVIE S E,et al.Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells[J].Infect Immun,2011,79(7):2535-2543.
|
10. |
赵琪,郭继中,黄学文,等.幽门螺杆菌VacA蛋白体外诱导胃上皮AGS细胞内HMGB1的表达[J].临床检验杂志,2011,29(4):279-281.
|
11. |
YE Huihui,WU Kejian,FEI Sujuan,et al.Propofol participates in gastric mucosal protection through inhibiting the toll-like receptor-4/nuclear factor kappa-B signaling pathway[J].Clin Res Hepatol Gastroenterol,2013,37(1):e3-15.
|
12. |
VITALI R,PALONE F,CUCCHIARA S,et al.Dipotassium glycyrrhizate inhibits HMGB1-dependent inflammation and ameliorates colitis in mice[J].PLoS One,2013,8(6):e66527.
|
13. |
TAKAISHI H,KANAI T,NAKAZAWA A,et al.Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA):accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype[J].J Gastroenterol,2012,47(9):969-977.
|
14. |
葛文松,吴建新,范建高.高迁移率族蛋白B1-Toll样受体途径与炎症性肠病[J].胃肠病学,2013,18(7):434-436.
|
15. |
VITALI R,STRONATI L,NEGRONI A,et al.Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease[J].Am J Gastroenterol,2011,106(11):2029-2040.
|
16. |
黄继英,韩冰,张顺财,等.甘草酸铵通过抑制HMGB1的表达减轻ConA诱导的免疫性肝损伤[J].胃肠病学和肝病学杂志,2012,21(3):264-267.
|
17. |
DRAGOMIR A C,LASKIN J D,LASKIN D L.Macrophage activation by factors released from acetaminophen-injured hepatocytes:Potential role of HMGB1[J].Toxicol Appl Pharmacol,2011,253(3):170-177.
|
18. |
YANG Zhongwei,DENG Yuxiao,SU Diansan,et al.TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia/reperfusion injury[J].Lab Invest,2013,93(7):792-800.
|
19. |
DENG Chunqing,DENG Guohong,WANG Yuming.HMGB1 gene polymorphisms in patients with chronic hepatitis B virus infection[J].World J Gastroenterol,2013,19(31):5144-5149.
|
20. |
段学章,胡瑾华,李晨,等.血清高迁移率族蛋白1在乙型肝炎病毒相关慢加急性肝衰竭患者中的特点及其临床意义[J].中华肝脏病杂志,2013,21(6):434-437.
|
21. |
SITIA G,IANNACONE M,MVLLER S,et al.Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice[J].J Leukoc Biol,2007,81(1):100-107.
|
22. |
夏敏,张婷,郭继中,等.高迁移率族蛋白1在急性坏死性胰腺炎伴器官功能损害中的作用及其抗体的保护作用[J].中华胰腺病杂志,2013,13(1):32-35.
|
23. |
LUAN Z G,ZHANG J,YIN X H,et al.Ethyl pyruvate significantly inhibits tumour necrosis factor-α,interleukin-1β and high mobility group box 1 releasing and attenuates Sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury[J].Clin Exp Immunol,2013,172(3):417-426.
|
24. |
KONG Xiangqian,ZHANG Caiqing,JIN Xing,et al.The effect of HMGB1 A box on lung injury in mice with acute pancreatitis[J].Biofactors,2011,37(4):323-327.
|
25. |
ANDERSSON U,TRACEY K J.HMGB1 is a therapeutic target for sterile inflammation and infection[J].Annu Rev Immunol,2011,29:139-162.
|
26. |
FINK M P.Ethyl pyruvate[J].Curr Opin Anaesthesiol,2008,21(2):160-167.
|
27. |
DIENER K R,AL-DASOOQI N,LOUSBERG E L,et al.The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and Cancer[J].Immunol Cell Biol,2013,91(7):443-450.
|
28. |
BISCETTI F,GHIRLANDA G,FLEX A.Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration[J].Curr Vasc Pharmacol,2011,9(6):677-681.
|
29. |
BENNETT-GUERRERO E,SWAMINATHAN M,GRIGORE AM,et al.A phase Ⅱ multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,2009,23(3):324-329.
|